Your browser doesn't support javascript.
loading
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.
Rosenstock, Julio; Frias, Juan; Jastreboff, Ania M; Du, Yu; Lou, Jitong; Gurbuz, Sirel; Thomas, Melissa K; Hartman, Mark L; Haupt, Axel; Milicevic, Zvonko; Coskun, Tamer.
Afiliação
  • Rosenstock J; Velocity Clinical Research at Medical City, Dallas, TX, USA.
  • Frias J; Velocity Clinical Research, Los Angeles, CA, USA.
  • Jastreboff AM; Department of Medicine (Endocrinology & Metabolism) and Department of Pediatrics (Pediatric Endocrinology), Yale University School of Medicine, New Haven, CT, USA.
  • Du Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Lou J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Gurbuz S; Eli Lilly and Company, Indianapolis, IN, USA.
  • Thomas MK; Eli Lilly and Company, Indianapolis, IN, USA.
  • Hartman ML; Eli Lilly and Company, Indianapolis, IN, USA.
  • Haupt A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Milicevic Z; Eli Lilly and Company, Indianapolis, IN, USA.
  • Coskun T; Eli Lilly and Company, Indianapolis, IN, USA. Electronic address: coskun_tamer@lilly.com.
Lancet ; 402(10401): 529-544, 2023 08 12.
Article em En | MEDLINE | ID: mdl-37385280
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos